
Oncology NEWS International
- Oncology NEWS International Vol 9 No 9
- Volume 9
- Issue 9
NBTF Introduces Neuroscience Nurse Consultations
OAKLAND, California-The National Brain Tumor Foundation (NBTF) has announced its new cancer online resource and toll-free telephone number. Patients and family members who have detailed medical questions regarding brain tumors can contact a neuroscience nurse for a free consultation.
OAKLAND, CaliforniaThe National Brain Tumor Foundation (NBTF) has announced its new cancer online resource and toll-free telephone number. Patients and family members who have detailed medical questions regarding brain tumors can contact a neuroscience nurse for a free consultation.
Our service is providing patients with the information to understand their treatment options, said Mary Lovely, RN, PhD, of the NBTF. The neuroscience nurses are experienced interviewers with advanced knowledge of the diseases and a great deal of sensitivity to patient needs, she added.
The Patient Information Line, 1-800-934-CURE, provides current disease-related information on tumor types, treatment, and coping. Information specialists are available to speak with callers Monday through Friday from 9 am to 5 pm Pacific Standard Time.
Callers may also use the automated response system to order free materials on brain tumors and obtain information about the foundation and its programs or leave a recorded message. All messages are returned the next business day.
Instant access to the foundations resources is available on its website, located at
The site also includes stories about other brain tumor survivors, a special pediatric page, and an illustrated guide to the brain.
Articles in this issue
almost 26 years ago
Soy’s Effect on Breast Cancer Remains Uncertainalmost 26 years ago
Comprehensive Eye Cancer Website Meets Needs of Both Patients and Physiciansalmost 26 years ago
STAR Enrollment Tops 6,000 in First Year of Recruitmentalmost 26 years ago
New rhTPO Being Tested in Three Trialsalmost 26 years ago
New Research Centers Target How Market Forces Affect Health Carealmost 26 years ago
Aromatase Inhibitors Actively Studied in Hormone-Dependent Breast Canceralmost 26 years ago
PRIMATOM System Combines CT Scanning With Radiation TherapyRelated Content


57 Altered Biomechanics Drives Outcome in Breast Cancer: A New Avenue for Oncology Biomarkers









































































